Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
J Vasc Surg. 2013 Feb;57(2):486-492.e2. doi: 10.1016/j.jvs.2012.07.007. Epub 2012 Nov 3.
Innate immunity drives numerous cardiovascular pathologies. Vein bypass grafting procedures are frequently accompanied by low-grade wound contamination. We hypothesized that a peri-graft innate immune challenge, via an outside-in route, augments inflammatory responses, which subsequently drive a component of negative vein graft wall adaptations; moreover, adipose tissue mediates this immune response.
The inferior vena cava from a donor mouse was implanted into the common carotid artery of a recipient mouse utilizing a validated cuff technique (9-week-old male C57BL/6J mice). Slow-release low-dose (5 μg) lipopolysaccharide (LPS) (n = 9) or vehicle (n = 9) was applied peri-graft; morphologic analysis was completed (day 28). In parallel, vein-grafted mice received peri-graft LPS (n = 12), distant subcutaneous LPS (n = 6), or vehicle (n = 12), then day-1 and -3 harvest of grafts and adipose tissue for cytokines and toll-like receptor (TLR) signaling mRNA expression (qRT-PCR).
All recipient mice survived, and all vein grafts were patent. Acute low-dose local LPS challenge enhanced vein graft lumen loss (P = .04) and tended to augment intimal hyperplasia (P = .06). The surgical trauma of vein grafting universally upregulated key pro- and anti-inflammatory mediators within the day-1 graft wall, but varied on TLR signaling gene expression. Local and distant LPS accentuated these patterns until at least postoperative day 3. LPS challenge enhanced the inflammatory response in adipose tissue (locally > distantly); local LPS upregulated adipose TLR-4 dramatically.
Perivascular and distant inflammatory challenges potentiate the magnitude and duration of inflammatory responses in the early vein graft wall, negatively modulating wall adaptations, and thus, potentially contribute to vein graft failure. Furthermore, surgery activates innate immunity in adipose tissue, which is augmented (regionally > systemically) by LPS. Modulation of these local and distant inflammatory signaling networks stands as a potential strategy to enhance the durability of vascular interventions such as vein grafts.
先天免疫可引发多种心血管病变。静脉旁路移植术常伴有轻微的伤口污染。我们假设,通过外向途径对移植部位周围的先天免疫进行挑战会增强炎症反应,进而导致静脉移植壁适应性的负面改变;此外,脂肪组织介导这种免疫反应。
采用已验证的套管技术(9 周龄雄性 C57BL/6J 小鼠),将供体小鼠的下腔静脉植入受体小鼠的颈总动脉。对移植部位周围给予缓慢释放的低剂量(5μg)脂多糖(LPS)(n=9)或载体(n=9);在第 28 天完成形态学分析。同时,静脉移植小鼠接受移植部位周围 LPS(n=12)、远处皮下 LPS(n=6)或载体(n=12),然后在第 1 天和第 3 天收获移植物和脂肪组织,用于细胞因子和 Toll 样受体(TLR)信号 mRNA 表达(qRT-PCR)。
所有受体小鼠均存活,所有静脉移植物均通畅。急性低剂量局部 LPS 刺激增强了静脉移植物管腔丢失(P=0.04),并倾向于增加内膜增生(P=0.06)。静脉移植的手术创伤普遍上调了第 1 天移植物壁内的关键促炎和抗炎介质,但 TLR 信号基因表达存在差异。局部和远处 LPS 至少在术后第 3 天之前增强了这些模式。LPS 刺激增强了脂肪组织中的炎症反应(局部>远处);局部 LPS 显著上调脂肪组织 TLR-4。
血管周围和远处的炎症刺激增强了早期静脉移植物壁中的炎症反应幅度和持续时间,对壁适应性产生负面影响,从而可能导致静脉移植物失败。此外,手术激活了脂肪组织中的先天免疫,而 LPS 会增强这种免疫(局部>全身)。调节这些局部和远处的炎症信号网络可能是增强血管介入(如静脉移植)耐久性的一种策略。